Search clinical trials for: CC-90010

Total 889 results

Celgene

Recruiting

A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma

Multiple Myeloma

United States, Israel, Spain, Denmark, France, Germany, Netherlands
Celgene

Completed

Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence (RESUME)

Primary Myelofibrosis | MPN-associated Myelofibrosis

United States, Netherlands, France, Australia, Italy, United Kingdom, Canada, Germany, China, Spain, Belgium, Austria, Poland, Sweden, Japan, Russian Federation
Sidney Kimmel Comprehensive Cancer Center at Johns...
Merck Sharp & Dohme LLC; Celgene Corporation

Completed

A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer

Colorectal Cancer

United States
University of California, San Francisco

Approved for marketing

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

Prostate Cancer | Prostate Adenocarcinoma | Prostate

United States
Universitaire Ziekenhuizen KU Leuven

Recruiting

High Precision Imaging of Prostate Specific Membrane Antigen for Personalized Treatment in Prostate Cancer

Prostate Cancer

Belgium
Novosanis NV

Completed

Proof Of Concept : Immunogenicity and Safety of hepB Injection in the Dermis Using VAX-ID (POC_VAX-ID)

Hepatitis B

Belgium
Jonsson Comprehensive Cancer Center

Completed

Gallium Ga 68-labeled PSMA-11 PET/CT and Fluciclovine F18 PET/CT in Imaging Participants With Recurrent Prostate Cancer After Surgery (PSMA vs AXUMIN)

Recurrent Prostate Carcinoma

United States
Baxter Healthcare Corporation

Completed

Comparison of the Clinical Performance of 3 THERANOVA 400 Dialyzer Prototypes With a High-Flux Dialyzer in Hemodialysis Mode

End Stage Renal Disease

Austria
Royal College of Surgeons, Ireland
Health Service Executive

Unknown

Creating a Proficiency-Based Virtual Reality Simulation Training Programme for Laparoscopic Assisted Colectomy (LAC)

Colorectal Disease

United Kingdom, Ireland
Thomas Hope

Completed

Gallium-68 PSMA-11 Positron Emission Tomography (PET) Imaging in Patients With Biochemical Recurrence

Prostate Cancer

United States
University of California, San Francisco

Completed

Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy Patients (PSMA PreRP)

Prostate Cancer

United States
Celgene

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Melanoma | Sarcoma | Neoplasms | Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Osteosarcoma | Glioblastoma Multiforme | Metastatic Breast... and other conditions

United States
Celgene

Terminated

Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Combination With Fulvestrant

Breast Neoplasms

Spain, United States, Belgium, Italy, France, Germany
Merz Therapeutics GmbH
Heinrich-Heine University, Duesseldorf

Recruiting

Assessment of Long-term Clinical Response to BoNT in Cervical Dystonia (RELY-CD)

Cervical Dystonia

Germany
University of California, San Francisco

Completed

Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence (PSMA BCR)

Prostate Cancer

United States
Celgene

Completed

Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitaxel Monotherapy as Second/Third-line Treatment for Advanced Non-small Cell Lung Cancer (abound2L+)

Carcinoma, Non-Small-Cell Lung

United States, Canada, France, Germany, Italy, Spain, United Kingdom
Sarepta Therapeutics, Inc.

Recruiting

An Observational Study Comparing Delandistrogene Moxeparvovec With Standard of Care in Participants With Duchenne Muscular Dystrophy (ENDURE)

Duchenne Muscular Dystrophy

United States
Dana-Farber Cancer Institute

Completed

Gut Decontamination In Pediatric Allogeneic Hematopoietic

Hematopoietic Stem Cell Transplantation (HSCT) | Acute GVH Disease

United States
University of Roma La Sapienza

Completed

Cinnamon and Withania on Weight Loss

Obesity

Italy
Amgen

Completed

A Study to Evaluate the Safety, Tolerability Pharmacokinetics, and Pharmacodynamics of a New Spray Dried Dispersion (SDD) Formulation of CC-11050 After Single Dose of CC-11050 and to Evaluate the Pharmacokinetics of CC-11050 Under Fasted and Fed Conditions and After Coadministration With Omeprazole

Healthy Volunteers

United States
Celgene Corporation

Completed

Safety Study of CC-292 and Rituximab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia Lymphocytic Chronic B-Cell

United States, Germany
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer

Lung Neoplasms | Respiratory Tract Neoplasms | Lung Cancer | Carcinoma, Non-Small Cell-Lung

Hong Kong, Korea, Republic of, Malaysia, Philippines, Singapore, Taiwan, Thailand
Fundación Santiago Dexeus Font

Recruiting

INTEnsity of ovariaN Stimulation and Embryo Quality (INTENS-EQ)

Infertility

Spain
Amgen

Completed

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Cutaneous Lupus Erythematosus

United States
Salvador Sarró, MD
Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de... and other collaborators

Completed

Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study

Schizophrenia

Spain
Jonsson Comprehensive Cancer Center
Janssen Scientific Affairs, LLC

Recruiting

Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial (HEATWAVE)

Prostate Adenocarcinoma | Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8

United States
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Active, not recruiting

68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancer

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Cancer Recurrent | Prostatic Cancer Metastatic

United States
Michael Graham PhD, MD
University of Iowa; Holden Comprehensive Cancer Center

Completed

68Ga PSMA in Preprostatectomy Patients

Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Prostatic Neoplasm | Prostatic Neoplasm of Uncertain Behavior

United States
Fakultas Kedokteran Universitas Indonesia

Unknown

A Trial Comparing Pain During Local Tumesent Injection In Fingers Using Different Syringe-Needle Combinations

Pain | Anesthesia, Local | Injection Site | Infiltration

Indonesia
St. Luke's Health System, Boise, Idaho
Patient-Centered Outcomes Research Institute; University of Pennsylvania; Columbia... and other collaborators

Active, not recruiting

Suicide Prevention Among Recipients of Care (SPARC)

Adolescent | Depressive Disorder | Depression | Suicidal Ideation | Suicide, Attempted | Suicide | Mental Health | Loneliness | Social Support | Mental Disorder | Outpatients | Ambulatory Care | Continuity of Patient Care | Adult | Secondary Prevention | Emergency Service, Hospital | Mental Health Services | Patient Care Planning and other conditions

United States
Weill Medical College of Cornell University

Completed

PSMA Imaging of Localized Prostate Cancer

Prostate Cancer

United States
Assiut University

Completed

Metformin Improves Clinical Pregnancy Rate in Polycystic Ovarian Syndrome Patients

Polycystic Ovarian Syndrome | Reproductive Endocrinology
Baker Heart and Diabetes Institute

Recruiting

Persistent Cardiovascular Effects of COVID-19 Viral Infection Trial (PERCEIVE)

Heart Failure

Australia
Celgene

Completed

A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers

Hematologic Neoplasms

Spain, United States
Celgene

Completed

A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)

Carcinoma, Hepatocellular

United States, Spain, Italy, France
Celgene

Completed

A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors

Carcinoma, Non-Small-Cell Lung | Urinary Bladder Neoplasms | Tumor Virus Infections | Ovarian Neoplasms | Fallopian Tube Neoplasms | Peritoneal Neoplasms | Carcinoma, Transitional Cell | Carcinoma, Pancreatic Ductal

Spain, United States, France, Netherlands
Ebrahim Delpassand
Excel Diagnostics and Nuclear Oncology Center; Radiomedix, Inc.

Recruiting

68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer (PSMA)

Prostate Cancer

United States
Medical University of Vienna
BSM Diagnostica GmbH Vienna; Siemens Healthcare GmbH

Completed

PET/MRI in Patients With Suspected Prostate Cancer

Prostate Cancer

Austria
Bristol-Myers Squibb

Recruiting

A Study to Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Hepatic Insufficiency | Neoplasms

Spain, United States, Germany, Argentina, Colombia, Greece
Celgene
AbbVie

Active, not recruiting

A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia

Leukemia, Myeloid, Acute

United States, Canada, France, United Kingdom, Belgium
Jeanne Link
Oregon Health and Science University; OHSU Knight Cancer Institute; OHSU Center...

Approved for marketing

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

Prostatic Neoplasms | Prostatic Diseases | Prostate Cancer | Prostate Cancer Recurrent | Prostate Cancer Metastatic

United States
Celgene

Completed

Relative Bioavailability and PPI Effects of CC-92480 Test and Reference Formulations in Healthy Subjects

Healthy Volunteer

United States
John Reneau
Bristol-Myers Squibb

Recruiting

Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia

T-Cell Large Granular Lymphocyte Leukemia

United States
Celgene

Terminated

Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer

Carcinoma, Hepatocellular

United States
Celgene Corporation

Terminated

Phase 1 Study of CC-486 in Japanese Subjects With Hematological Neoplasms

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Multiple Myeloma | Hodgkin Lymphoma | Chronic Myelomonocytic Leukemia | Non-Hodgkin Lymphoma

Japan
Duke University

Completed

Postoperative Subtenons Anesthesia for Postoperative Pain in Pediatric Strabismus Surgery

Strabismus

United States
AVEO Pharmaceuticals, Inc.

Completed

A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma (P05538)

Multiple Myeloma | Lymphomas | Malignant Solid Tumor

United States
University of Pennsylvania
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Understanding the Sleep Apnea/Insomnia Interaction

Sleep Apnea Syndromes | Sleep Initiation and Maintenance Disorders

United States
Celgene

Active, not recruiting

A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb) in Subjects With Relapsed or Refractory Lymphomas

Lymphoma

United States, France, Germany, Italy, Korea, Republic of, Taiwan
Celgene

Active, not recruiting

A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hematologic Cancers

Neoplasms

United States, France, Australia, Canada, Italy, Korea, Republic of, Spain, United Kingdom

Search clinical trials for: CC-90010

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Gambia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations